New hope for rare seizure disorders: Long-Term drug safety trial underway
NCT ID NCT06908226
First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 26 times
Summary
This study is testing the long-term safety and effectiveness of an investigational drug called LP352 for controlling seizures in children and adults with developmental and epileptic encephalopathy (DEE), a group of severe brain disorders. About 324 people who completed earlier studies will take LP352 for around 14 months. The goal is to see if the drug remains safe and helps reduce seizures over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP - Hôpital universitaire Robert-Debré
Paris, 75019, France
-
Arkansas Children's Hospital - PIN
Little Rock, Arkansas, 72202-3500, United States
-
Austin Hospital
Heidelberg, Victoria, 3084, Australia
-
Children's Clinical University Hospital
Riga, LV-1004, Latvia
-
David Geffen School of Medicine at UCLA
Los Angeles, California, 90095, United States
-
Hospital Ruber Internacional (Grupo Quironsalud)
Madrid, 28034, Spain
-
Hospital Universitario Vithas Madrid La Milagrosa
Madrid, 28010, Spain
-
Hospital de La Santa Creu i Sant Pau
Barcelona, 8041, Spain
-
Institute of Neurology and Neurosurgery at Saint Barnabas, LLC
Livingston, New Jersey, 07039-5817, United States
-
Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland, 20817-1809, United States
-
Mother and Child Health Care Institute of Serbia Dr Vukan Cupic
Belgrade, 11000, Serbia
-
NW FL Clinical Research Group, LLC
Gulf Breeze, Florida, 32561-4458, United States
-
Northeast Regional Epilepsy Group - Morristown - 310 Madison Ave
Morristown, New Jersey, 07960, United States
-
Pediatric Epilepsy and Neurology Specialists
Tampa, Florida, 33609-4181, United States
-
Research Institute of Orlando LLC
Orlando, Florida, 32806-5411, United States
-
The University of Texas Medical School at Houston
Houston, Texas, 77030-3000, United States
Conditions
Explore the condition pages connected to this study.